COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY

被引：1
|
作者：
Townsend, Tristan [1 ]
Razanskaite, Violeta [2 ]
Michail, Stephanie [1 ]
Morgan, James [1 ]
Davies, Michael [1 ]
Storey, Daniel [1 ]
Watters, Christopher [3 ]
Penman, Douglas [3 ]
Swaminathan, Mira [4 ]
Reilly, Ian [4 ]
Flanagan, Paul
Subramanian, Sreedhar [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[2] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
[3] Arrowe Pk Hosp, Upton, England
[4] Countess Chester Hosp, Chester, Cheshire, England
来源：
GUT | 2021年 / 70卷
关键词：
D O I：
10.1136/gutjnl-2020-bsgcampus.237
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P162
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [1] Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study
    Townsend, T.
    Razanskaite, V.
    Michail, S.
    Morgan, J.
    Davies, M.
    Storey, D.
    Watters, C.
    Penman, D.
    Swaminathan, M.
    Sabine, J.
    Chapman, A.
    Vyas, A.
    Reilly, I.
    Flanagan, P.
    Bodger, K.
    Subramanian, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S407 - S408
  • [2] MULTI-CENTRE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB AS INDUCTION THERAPY IN ANTI-TNF REFRACTORY CROHN'S DISEASE
    Razanskaite, Violeta
    Michail, Stephanie
    Morgan, James
    Davies, Michael
    Storey, Daneil
    Watters, Christopher
    Penman, Douglas
    Swaminathan, Mira
    Sabine, Joseph
    Chapman, Adam
    Reilly, Ian
    Flanagan, Paul
    Bodger, Keith
    Subramanian, Sreedhar
    [J]. GUT, 2019, 68 : A100 - A100
  • [3] Effectiveness of ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor: A multi-centre comparative study
    Alric, H.
    Amiot, A.
    Kirchgesner, J.
    Treton, X.
    Allez, M.
    Bouhnik, Y.
    Beaugerie, L.
    Carbonnel, F.
    Meyer, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S118 - S120
  • [4] Comparative Effectiveness of Vedolizumab Versus Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease
    Kappelman, Michael
    Lewis, James D.
    Zhang, Xian
    Lin, Feng-Chang
    Weisbein, Laura
    Chen, Wenli
    Burris, Jessica L.
    Dorand, Jennifer E.
    Parlett, Lauren E.
    Haynes, Kevin
    Nair, Vinit
    Kaul, Alan F.
    Dobes, Angela
    Long, Millie
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S676 - S676
  • [5] The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab
    Kassouri, Liza
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (10) : 1148 - 1155
  • [6] Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease: A Review of Comparative Effectiveness Studies
    Sharip, Mohmmed Tauseef
    Nishad, Nilanga
    Pillay, Lushen
    Goordoyel, Nilkantsingh
    Goerge, Samuel
    Subramanian, Sreedhar
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [7] Ustekinumab and anti-TNF agents are equally safe and effective in elderly Crohn's disease patients: A propensity adjusted multi-centre cohort study
    Gebeyehu, G. G.
    Broglio, G.
    Liu, E.
    Limdi, J. K.
    Selinger, C.
    Fiske, J.
    Razsanskaite, V.
    Smith, P. J.
    Flanagan, P. K.
    Subramanian, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 723 - 724
  • [8] Ustekinumab and anti-TNF agents are equally safe and effective in elderly crohn's disease patients: A propensity adjusted multi-centre cohort study
    Gebeyehu, Gerum Gashaw
    Broglio, Giacomo
    Liu, Eleanor
    Limdi, Jimmy K.
    Selinger, Christian
    Fiske, Joseph
    Razsanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    [J]. GUT, 2023, 72 (SUPPL_2) : A73 - A74
  • [9] Effectiveness of ustekinumab in fistulising perianal Crohn's disease refractory or intolerant to anti-TNF
    Carpio, D.
    Calvino-Suarez, C.
    Martinez-Cadilla, J.
    Molina, G.
    Vazquez-Rey, M. T.
    Marti, E.
    Fernandez-Salgado, E.
    Acosta, M. Barreiro-de
    Hernandez, V.
    Echarri, A.
    Diz-Lois, M. T.
    Baz, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S419 - S420
  • [10] Strategy of selecting anti-TNF agent in patients with Crohn's disease: A multi-centre retrospective cohort study by the Osaka gut forum
    Amano, T.
    Shinzaki, S.
    Tashiro, T.
    Otake, Y.
    Tani, M.
    Yoshihara, T.
    Iwatani, S.
    Tsujii, Y.
    Inoue, T.
    Hayashi, Y.
    Iijima, H.
    Takehara, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S551 - S551
12345